[JAKARTA] Indonesia signed an agreement with China's Sinovac Biotech for 50 million doses of a Covid-19 vaccine concentrate that will allow state-owned Bio Farma to produce doses locally. Read more at The Business Times.
Indonesia signed an agreement with China's Sinovac Biotech for 50 million doses of a Covid-19 vaccine concentrate that will allow state-owned Bio Farma to produce doses locally.[JAKARTA] Indonesia signed an agreement with China's Sinovac Biotech for 50 million doses of a Covid-19 vaccine concentrate that will allow state-owned Bio Farma to produce doses locally.
Sinovac will ship the concentrate in five equal stages between November and March, vaccine maker Bio...
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Indonesia signs agreement with Sinovac for Covid-19 vaccineJAKARTA (BLOOMBERG) - Indonesia signed an agreement with China's Sinovac Biotech for 50 million doses of Covid-19 vaccine concentrate that will allow state-owned PT Bio Farma to produce doses locally.. Read more at straitstimes.com.
Read more »
Indonesia books 40 million COVID-19 vaccine doses from SinovacJAKARTA: China's Sinovac Biotech has committed to provide up to 40 million COVID-19 vaccine doses to Indonesia's government between November and ...
Read more »
Singapore researchers discover milder COVID-19 strain, opening up new avenues for treatment and vaccine developmentSINGAPORE: Researchers in Singapore have discovered a new COVID-19 variant that causes less severe symptoms in patients, opening up new avenues ...
Read more »
Russia COVID-19 vaccine roll-out plan prompts virus mutation worriesLONDON: Russia's plan to roll-out its 'Sputnik-V' COVID-19 vaccine even before full trials show how well it works is prompting concern among virus ...
Read more »
Russia approves trial of AstraZeneca COVID-19 vaccine: registry filingAstraZeneca has received regulatory approval to conduct part of a Phase III trial of its potential COVID-19 vaccine, AZD1222, in Russia, a filing ...
Read more »
Russia approves trial of AstraZeneca Covid-19 vaccine: registry filing[MOSCOW] Britain's AstraZeneca has received regulatory approval to conduct part of a Phase Three trial of its potential Covid-19 vaccine in Russia, a filing in the Russian registry of clinical trials showed on Friday. Read more at The Business Times.
Read more »